26 October 2020
Latham & Watkins Advises Underwriters in Foghorn Therapeutics’ IPO
Advising firms
Deal team
7 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| Pete Handrinos Lead | Latham & Watkins LLP | Partner | capital markets | Not stated |
| Wesley Holmes Lead | Latham & Watkins LLP | Partner | capital markets | Not stated |
| Jennifer Yoon | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Brian Yoon | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Michael Casagrande | Latham & Watkins LLP | Associate | capital markets | Not stated |
| Jocelyn Noll | Latham & Watkins LLP | Partner | tax | Not stated |
| Joseph Curran | Latham & Watkins LLP | Associate | tax | Not stated |
4 more lawyers on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 120m (US$120 million)
- What the figure measures
- Issue size
- Client
- Latham & Watkins LLPUnderwriters
- Counterparties
- Foghorn Therapeutics Inc. (Issuer)